QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
NYSE:BME

BlackRock Health Sciences Trust Stock Forecast, Price & News

$47.88
+2.14 (+4.68 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$46.17
Now: $47.88
$47.88
50-Day Range
$45.74
MA: $48.45
$50.31
52-Week Range
$27.00
Now: $47.88
$50.94
Volume30,023 shs
Average Volume35,770 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.06%
BetaN/A
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Industry, Sector and Symbol

Industry Closed-End Fund - Equity
Sub-IndustryN/A
SectorFinance
CUSIPN/A
Phone+1-800-8820052
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.48 out of 5 stars

Finance Sector

1631st out of 1,938 stocks

Closed-End Fund - Equity Industry

6th out of 7 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$47.88
+2.14 (+4.68 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BME News and Ratings via Email

Sign-up to receive the latest news and ratings for BME and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BlackRock Health Sciences Trust (NYSE:BME) Frequently Asked Questions

Is BlackRock Health Sciences Trust a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BlackRock Health Sciences Trust in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" BlackRock Health Sciences Trust stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BME, but not buy additional shares or sell existing shares.
View analyst ratings for BlackRock Health Sciences Trust
or view top-rated stocks.

What stocks does MarketBeat like better than BlackRock Health Sciences Trust?

Wall Street analysts have given BlackRock Health Sciences Trust a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BlackRock Health Sciences Trust wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust saw a decrease in short interest during the month of January. As of January 29th, there was short interest totaling 34,700 shares, a decrease of 21.5% from the January 14th total of 44,200 shares. Based on an average daily trading volume, of 34,900 shares, the days-to-cover ratio is currently 1.0 days.
View BlackRock Health Sciences Trust's Short Interest
.

How has BlackRock Health Sciences Trust's stock price been impacted by Coronavirus?

BlackRock Health Sciences Trust's stock was trading at $37.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BME shares have increased by 28.5% and is now trading at $47.88.
View which stocks have been most impacted by COVID-19
.

How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust declared a monthly dividend on Monday, February 1st. Stockholders of record on Tuesday, February 16th will be paid a dividend of $0.20 per share on Friday, February 26th. This represents a $2.40 annualized dividend and a yield of 5.01%. The ex-dividend date is Friday, February 12th.
View BlackRock Health Sciences Trust's dividend history
.

Is BlackRock Health Sciences Trust a good dividend stock?

BlackRock Health Sciences Trust pays an annual dividend of $2.40 per share and currently has a dividend yield of 0.06%.
View BlackRock Health Sciences Trust's dividend history.

Who are BlackRock Health Sciences Trust's key executives?

BlackRock Health Sciences Trust's management team includes the following people:
  • Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 54)
  • Mr. Thomas P. Callan C.F.A., CFA, Portfolio Mang.
  • Mr. Michael D. Carey, Portfolio Mang.
  • Mr. Kyle G. McClements CFA, Portfolio Mang.
  • Dr. Erin Xie, Portfolio Mang. (Age 53)
  • Mr. Christopher M. Accettella, Portfolio Mang.
  • Mr. Jeffrey Gene Lee, Portfolio Mang.
  • Dr. Xiang Liu Ph.D., Portfolio Mang.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust CEO Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among BlackRock Health Sciences Trust's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of BlackRock Health Sciences Trust's key competitors?

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and The Procter & Gamble (PG).

What is BlackRock Health Sciences Trust's stock symbol?

BlackRock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's stock is owned by many different retail and institutional investors. Top institutional shareholders include Morgan Stanley (0.00%), Wells Fargo & Company MN (0.00%), Ahrens Investment Partners LLC (0.00%), Cambridge Investment Research Advisors Inc. (0.00%), LPL Financial LLC (0.00%) and HighTower Advisors LLC (0.00%).
View institutional ownership trends for BlackRock Health Sciences Trust
.

Which institutional investors are selling BlackRock Health Sciences Trust stock?

BME stock was sold by a variety of institutional investors in the last quarter, including Raymond James Financial Services Advisors Inc., Blue Bell Private Wealth Management LLC, HighTower Advisors LLC, Truist Financial Corp, and Janney Montgomery Scott LLC.
View insider buying and selling activity for BlackRock Health Sciences Trust
or view top insider-selling stocks.

Which institutional investors are buying BlackRock Health Sciences Trust stock?

BME stock was acquired by a variety of institutional investors in the last quarter, including Ahrens Investment Partners LLC, Diversified LLC, Wells Fargo & Company MN, LPL Financial LLC, Kestra Advisory Services LLC, Morgan Stanley, M&T Bank Corp, and Cambridge Investment Research Advisors Inc..
View insider buying and selling activity for BlackRock Health Sciences Trust
or or view top insider-buying stocks.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BlackRock Health Sciences Trust's stock price today?

One share of BME stock can currently be purchased for approximately $47.88.

What is BlackRock Health Sciences Trust's official website?

The official website for BlackRock Health Sciences Trust is www2.blackrock.com.

Where are BlackRock Health Sciences Trust's headquarters?

BlackRock Health Sciences Trust is headquartered at 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States.

How can I contact BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.